Suwon-si, South Korea

Chang Ki Lim

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 6.3

ph-index = 6

Forward Citations = 144(Granted Patents)


Location History:

  • Suwon-si, KR (2010 - 2018)
  • Hwaseong-si, KR (2014 - 2022)
  • Gyeonggi-do, KR (2019 - 2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: The Innovative Journey of Inventor Chang Ki Lim

Introduction

Chang Ki Lim is an accomplished inventor based in Suwon-si, South Korea, known for his significant contributions to the field of biomedical innovations. With a remarkable portfolio of 15 patents, he has focused on developing novel treatments for obesity through innovative glucagon derivatives.

Latest Patents

Among his latest patents is a groundbreaking invention relating to glucagon derivatives. This novel peptide serves as a composition for preventing or treating obesity, with its active ingredient demonstrating enhanced activating effects on both glucagon-like peptide-1 receptors and glucagon receptors compared to native glucagon. This innovative glucagon derivative presents remarkable potential as an effective agent for obesity treatment. Another notable patent by Chang Ki Lim is the development of a triple glucagon/GLP-1/GIP receptor agonist. This triple agonist displays activities targeting all three receptors—glucagon, GLP-1, and GIP—and its diverse applications further contribute to the advancing research in obesity management.

Career Highlights

Throughout his career, Chang Ki Lim has worked with prominent companies such as Hanmi Pharmaceutical Co., Ltd. and Hanmi Science Co., Ltd. His experience in these esteemed organizations has greatly influenced his innovative pursuits, allowing him to translate scientific research into practical solutions for obesity treatment.

Collaborations

Chang Ki Lim has collaborated with notable colleagues like Se Chang Kwon and Sung Youb Jung. These partnerships have enabled the synergy of ideas and expertise, further enhancing his contributions to the field of obesity research.

Conclusion

As an inventor, Chang Ki Lim has made substantial strides in addressing obesity through his innovative patents. His work not only reflects his commitment to scientific advancement but also exemplifies the transformative potential of innovation in healthcare. With ongoing research and collaboration, the impact of his inventions will continue to resonate in the fight against obesity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…